| Identification | Back Directory | [Name]
MK-2048 | [CAS]
870005-19-9 | [Synonyms]
CS-235
MK-2048
(6S)-2-[(3-Chloro-4-fluorophenyl)methyl]-N,8-diethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-6-methyl
(6S)-2-[(3-chloro-4-fluorophenyl)Methyl]-N,8-diethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-6-Methyl-1,9-dioxo-
(6S)-2-[(3-Chloro-4-fluorophenyl)methyl]-N,8-diethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-6-methyl-1,9-dioxo-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-4-carboxam
(6S)-2-[(3-chloro-4-fluorophenyl)methyl]-N,8-diethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-6-methyl-1,9-dioxo-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide
Pyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide, 2-[(3-chloro-4-fluorophenyl)methyl]-N,8-diethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-6-methyl-1,9-dioxo-, (6S)- | [Molecular Formula]
C22H23ClFN5O4 | [MOL File]
870005-19-9.mol | [Molecular Weight]
475.9 |
| Chemical Properties | Back Directory | [Melting point ]
>240°C (dec.) | [density ]
1.52±0.1 g/cm3(Predicted) | [storage temp. ]
-20°C Freezer | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
6.52±0.40(Predicted) | [color ]
Yellow |
| Hazard Information | Back Directory | [Uses]
MK-2048 represents a prototype second generation integrase strand transfer inhibitor (INSTI), it was developed with the goal of retaining activity against viruses containing mutations assiciated with resistance of first-generation INSTIs, raltegravir (R100312). MK-2048 exhibits inhibitory activity towards HIV integrase and towards HIV replication. It is four times more effective in inhibiting HIV enzyme integrase than the first generation inhibitor, raltegravir. |
|
|